OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 3,748 ALKS derivative securities | OQRO

Home
Insider trades
Alkermes plc
Officer exercised or converted 3,748 ALKS derivative securities

Insider trades

Insider trade

Officer exercised or converted 3,748 ALKS derivative securities

Traded Dec 3, 2025 · Filed Dec 5, 2025

ALKAlkermes plcALKS

3,748
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 3, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 5, 2025

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001520262-25-000014

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Dec 5, 2025, 9:21 PM UTC

Added to OQRO

Oct 6, 2026, 9:54 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Alkermes plc.

Issuer CIK

1520262

Ticker

ALKS

Reporting person

Craig C. Hopkinson

Relationship

Officer

Officer title

EVP R&D, Chief Medical Officer

Security

Employee Stock Option (Right to Buy)

Table

Derivative (Table II)

Transaction date

Dec 3, 2025

Transaction code

Shares / units

3,748

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

36,356

Ownership form

Direct

Amendment

Footnotes from the filing

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
These options are fully vested in accordance with their terms.

Around the same time

Craig C. Hopkinson (EVP R&D, Chief Medical Officer) sold ~$112K of Alkermes plc

Scheduled in advanceFiled 9mo ago

Craig C. HopkinsonEVP R&D, Chief Medical Officer

Filed 10mo ago

3,748Shares · @ $19.34

Traded Dec 3, 2025 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Craig C. Hopkinson (EVP R&D, Chief Medical Officer) sold ~$112K of Alkermes plc

Scheduled in advanceFiled 10mo ago